Gregory K. Bergey
National Institutes of Health
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Gregory K. Bergey.
Brain Research | 1981
Gregory K. Bergey; S.C. Fitzgerald; Bruce K. Schrier; Phillip G. Nelson
Fetal mouse spinal cord (SC) and dorsal root ganglion (DRG) neurons undergo a process of maturation in cell culture lasting a month or more. We have investigated the role of electrical activity in this maturational process with the use of tetrodotoxin (TTX), the specific blocker of the voltage-sensitive sodium channel responsible for action potential generation. This agent completely eliminates the spikes and related synaptic activity which occur abundantly in untreated cultures. Such blockade of electrical activity in the cultures, when begun early (day 1 or day 8 in vitro), results in a 85-95% reduction in the number of large SC neurons, without affecting DRG neuron numbers. TTX treatment initiated when cultures are mature (day 70) has no significant effect on either DRG or SC neurons. Intermediate effects are obtained when treatment is initiated at day 35 in vitro. The activity of the nerve-specific enzyme choline acetyltransferase, is significantly decreased by early TTX treatment, while DNA and protein content of the cultures (primarily contributed by glial and fibroblastic cells) is not affected.
Journal of Neurochemistry | 2006
William H. Habig; Hans Bigalke; Gregory K. Bergey; Elaine A. Neale; M. Carolyn Hardegree; Phillip G. Nelson
Abstract: The clinical course of tetanus is notable, in addition to its often dramatic clinical presentation, by the long duration of the neuromuscular symptoms. Survivors may have tetanic manifestations for several weeks after the onset of the disease. In this article we correlate the duration of specific electrophysiologic effects produced by tetanus toxin with the degradation of cell‐associated toxin in primary cultures of mouse spinal cord neurons. From these studies we can conclude that the toxin has a half‐life of 5–6 days. Both the heavy and the light chains of tetanus toxin degrade at similar rates. Labeled toxin, visualized by radioautography, is associated with neuronal cell bodies and neurites, and its distribution is not altered during a 1‐week period following toxin exposure. Blockade of synaptic activity persists for weeks at the concentration of radiolabeled toxin used in these studies. This blockade of transmission is reversed as the toxin is degraded, suggesting that degradation of toxin may be a sufficient mechanism for recovery from tetanus.
Brain Research | 1981
Eric J. Heyer; Robert L. Macdonald; Gregory K. Bergey; Phillip G. Nelson
Following blockade of membrane potassium conductance with tetraethylammonium ions or 3-aminopyridine, long-duration action potentials were recorded from mouse spinal cord neurons in primary dissociated cell culture. The action potentials were calcium-dependent since they: (1) were not blocked by the sodium-channel blocker tetrodotoxin, (2) could be recorded in sodium-free, calcium-containing medium (3) could not be evoked in sodium-containing, calcium-free medium, (4) were blocked by calcium channel blockers manganese and cobalt and (5) had overshoot amplitudes that varied linearly with the log of the extracellular calcium concentration (slope of 27.5 mV/decade change in calcium concentration).
Brain Research | 1980
Gregory K. Bergey; Michael R. Martin; Manfred Hermes
Abstract The effects of the dicar☐ylic amino acid, dl -α-aminoadipate (DLAA) on amino acid responses have been investigated using intracellular recordings from mouse spinal cord neurons grown in dissociated cell culture. dl -α-Aminoadipate markedly antagonized postsynaptic responses to iontophoretically applied aspartate; antagonism of glutamate was much less prominent. dl -α-Aminoadipate altered the affinity of aspartate for its receptor while having no observed effects on aspartate-receptor cooperativity. No direct effects of DLAA on membrane potentials or passive membrane properties were seen at the currents used for antagonism. Responses to the inhibitory amino acids GABA and glycine were unaffected by DLAA.
Brain Research | 1979
Robert L. Macdonald; Gregory K. Bergey
Journal of Neurophysiology | 1987
Gregory K. Bergey; H. Bigalke; Phillip G. Nelson
The Journal of Neuroscience | 1983
Gregory K. Bergey; Robert L. Macdonald; Wh Habig; Mc Hardegree; Phillip G. Nelson
Annals of Neurology | 1981
Gregory K. Bergey; Kenneth F. Swaiman; Bruce K. Schrier; S.C. Fitzgerald; Phillip G. Nelson
Transactions of the American Neurological Association | 1978
Robert L. Macdonald; Gregory K. Bergey
Archive | 1981
Gregory K. Bergey; Phillip G. Nelson; Robert L. Macdonald; William H. Habig